Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Historical Holders from Q3 2021 to Q3 2025

Symbol
ATXS on Nasdaq
CUSIP
04635X102
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
56.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
56M
Holdings value
$408M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
113
Number of buys
50
Number of sells
-49
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 11.5% $47.2M 6.49M Perceptive Advisors LLC Oct 14, 2025
Vestal Point Capital, LP 8.8% $36.1M 4.96M Vestal Point Capital, LP Sep 30, 2025
Magnetar Financial LLC 5.87% $24.1M 3.31M Magnetar Financial LLC Oct 17, 2025
Venrock Healthcare Capital Partners III, L.P. 4.4% $10M 2.46M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
Fairmount Funds Management LLC 4% -59% $17.3M -$25.4M 2.38M -59.5% Fairmount Funds Management LLC Oct 14, 2025
FMR LLC 2.2% -76.7% $9.11M -$28.4M 1.25M -75.7% FMR LLC Oct 31, 2025
INTEGRATED CORE STRATEGIES (US) LLC 0.4% -96% $1.62M -$19.8M 222K -92.4% Millennium Management LLC Oct 14, 2025

Institutional Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 56M $408M -$10.3M $7.28 113
2025 Q2 57.6M $310M -$4.21M $5.36 105
2025 Q1 58.3M $311M -$2.82M $5.34 112
2024 Q4 58.6M $524M +$15.5M $8.94 108
2024 Q3 56.5M $622M +$12.4M $11.01 102
2024 Q2 55.6M $506M -$43M $9.10 100
2024 Q1 55.1M $775M +$330M $14.08 93
2023 Q4 13.6K $105K -$86.8K $7.68 1
2023 Q3 23M $171M -$12.4M $7.46 68
2023 Q2 24.6M $205M +$5.96M $8.33 75
2023 Q1 23.4M $312M +$19.6M $13.30 66
2022 Q4 21.8M $325M +$180M $14.89 59
2022 Q3 9.83M $88.8M +$41.6M $9.04 40
2022 Q2 5.73M $17.2M -$3.74M $3.00 27
2022 Q1 6.21M $41.7M +$890K $6.71 30
2021 Q4 6.09M $32.8M -$7.41M $5.39 30
2021 Q3 7.21M $63.8M +$63.8M $8.84 35